● Recruiting

Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))

Condition: Erythema Migrans of Lyme Disease · Sponsor: Biocodex

PhasePhase 4

Planned participants120

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The aim of this study is to assess the effect of Saccharomyces boulardii CNCM I-745 on gut microbiota in patients undergoing antibiotic therapy (in the context of erythema migrans (early skin form of Lyme borreliosis)).

This description comes directly from the study's public registry record.

Talk to the study team

Gaëlle MARIAULE · 03.44.86.82.28 · g.mariaule@biocodex.fr

Carine FRANCOIS · 03.44.86.82.28 · c.francois@biocodex.fr

Always discuss trial participation with your own doctor first.

Locations (1)

University Medical Centre Ljubljana

Ljubljana, Slovenia

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06451913